JP2015516949A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015516949A5 JP2015516949A5 JP2015502339A JP2015502339A JP2015516949A5 JP 2015516949 A5 JP2015516949 A5 JP 2015516949A5 JP 2015502339 A JP2015502339 A JP 2015502339A JP 2015502339 A JP2015502339 A JP 2015502339A JP 2015516949 A5 JP2015516949 A5 JP 2015516949A5
- Authority
- JP
- Japan
- Prior art keywords
- nanoparticle aggregate
- aggregate according
- biofilm
- nanoparticle
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002105 nanoparticle Substances 0.000 claims 18
- 239000002245 particle Substances 0.000 claims 7
- 201000010099 disease Diseases 0.000 claims 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 6
- 102000004264 Osteopontin Human genes 0.000 claims 5
- 108010081689 Osteopontin Proteins 0.000 claims 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 4
- 229910052791 calcium Inorganic materials 0.000 claims 4
- 239000011575 calcium Substances 0.000 claims 4
- 229910052712 strontium Inorganic materials 0.000 claims 3
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 claims 3
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 206010048038 Wound infection Diseases 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 229910017053 inorganic salt Inorganic materials 0.000 claims 2
- 230000000813 microbial effect Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- 206010064687 Device related infection Diseases 0.000 claims 1
- 206010014666 Endocarditis bacterial Diseases 0.000 claims 1
- 208000025157 Oral disease Diseases 0.000 claims 1
- 206010033078 Otitis media Diseases 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 208000009361 bacterial endocarditis Diseases 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000002925 dental caries Diseases 0.000 claims 1
- 208000007565 gingivitis Diseases 0.000 claims 1
- 201000007119 infective endocarditis Diseases 0.000 claims 1
- 208000030194 mouth disease Diseases 0.000 claims 1
- 201000001245 periodontitis Diseases 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12161802 | 2012-03-28 | ||
| EP12161802.9 | 2012-03-28 | ||
| PCT/EP2013/056598 WO2013144247A1 (en) | 2012-03-28 | 2013-03-27 | Nanoparticle aggregates containing osteopontin and calcium- and/or strontium-containing particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015516949A JP2015516949A (ja) | 2015-06-18 |
| JP2015516949A5 true JP2015516949A5 (https=) | 2016-06-02 |
Family
ID=48141914
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015502339A Pending JP2015516949A (ja) | 2012-03-28 | 2013-03-27 | オステオポンチンとカルシウムおよび／またはストロンチウム含有粒子とを含有するナノ粒子凝集体 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20150044260A1 (https=) |
| EP (1) | EP2830647A1 (https=) |
| JP (1) | JP2015516949A (https=) |
| KR (1) | KR20150004814A (https=) |
| CN (1) | CN104321073A (https=) |
| AR (1) | AR090569A1 (https=) |
| AU (1) | AU2013241750A1 (https=) |
| CA (1) | CA2868684A1 (https=) |
| CL (1) | CL2014002583A1 (https=) |
| EA (1) | EA201491691A1 (https=) |
| MX (1) | MX2014011594A (https=) |
| NZ (1) | NZ700295A (https=) |
| WO (1) | WO2013144247A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5548121B2 (ja) | 2007-05-14 | 2014-07-16 | リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク | バイオフィルム中の細菌細胞における生理学的分散応答の誘導 |
| US12109284B2 (en) | 2016-11-08 | 2024-10-08 | Dentherapy Ltd | Compositions comprising fluoride and calcium and method for preparing them |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| US20220183933A1 (en) * | 2019-03-22 | 2022-06-16 | The Board Of Regents Of The University Of Oklahoma | Surface-modified doped titanium dioxide nanoparticles and uses |
| CN111366733B (zh) * | 2020-03-07 | 2022-02-08 | 浙江大学 | 骨桥蛋白作为靶分子在调节肠道菌群定植中的应用 |
| EP4129413A4 (en) * | 2020-03-27 | 2024-04-24 | NOF Corporation | Composition for oral cavity |
| GB202010987D0 (en) | 2020-07-16 | 2020-09-02 | Dentherapy Ltd | Oral care compositions and methods |
| GB202110114D0 (en) | 2021-07-14 | 2021-08-25 | Dentherapy Ltd | Oral care compositions for use in treaatment |
| WO2023187028A1 (en) * | 2022-03-31 | 2023-10-05 | Nadavia Holding Aps | Mouthwash composition comprising one or more strontium salt |
| WO2025008636A1 (en) | 2023-07-06 | 2025-01-09 | Dentherapy Ltd | Oral care compositions for use in the treatment of dental health conditions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7259243B2 (en) * | 2000-01-07 | 2007-08-21 | Arla Foods Amba | Process for isolation of osteopontin from milk |
| NZ507335A (en) | 2000-10-05 | 2004-10-29 | New Zealand Dairy Board | Bone health compositions derived from milk comprising an acidic protein fraction but that does not contain CGMP |
| CN1889922B (zh) | 2003-12-01 | 2010-11-24 | 阿尔拉食品公司 | 骨桥蛋白在牙用制剂中的用途 |
| EA200870058A1 (ru) * | 2005-12-16 | 2008-12-30 | Арла Фудс Амба | Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран |
| EP2175841A1 (en) * | 2007-07-16 | 2010-04-21 | Aarhus Universitet | Osteopontin nanoparticles system for drug delivery |
| AU2012222312B2 (en) | 2011-03-03 | 2017-06-08 | Arla Foods Amba | Method for isolating osteopontin using feeds containing cmp or casein species |
-
2013
- 2013-03-27 MX MX2014011594A patent/MX2014011594A/es unknown
- 2013-03-27 CA CA2868684A patent/CA2868684A1/en not_active Abandoned
- 2013-03-27 US US14/387,946 patent/US20150044260A1/en not_active Abandoned
- 2013-03-27 JP JP2015502339A patent/JP2015516949A/ja active Pending
- 2013-03-27 EP EP13717196.3A patent/EP2830647A1/en not_active Withdrawn
- 2013-03-27 NZ NZ700295A patent/NZ700295A/en not_active IP Right Cessation
- 2013-03-27 AU AU2013241750A patent/AU2013241750A1/en not_active Abandoned
- 2013-03-27 KR KR1020147029790A patent/KR20150004814A/ko not_active Withdrawn
- 2013-03-27 WO PCT/EP2013/056598 patent/WO2013144247A1/en not_active Ceased
- 2013-03-27 EA EA201491691A patent/EA201491691A1/ru unknown
- 2013-03-27 CN CN201380025647.3A patent/CN104321073A/zh active Pending
- 2013-04-03 AR ARP130101064A patent/AR090569A1/es unknown
-
2014
- 2014-09-26 CL CL2014002583A patent/CL2014002583A1/es unknown
-
2016
- 2016-04-05 US US15/091,499 patent/US20170065673A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015516949A5 (https=) | ||
| Liu et al. | Graphene oxide–silver nanocomposites modulate biofilm formation and extracellular polymeric substance (EPS) production | |
| Fan et al. | Calcium-silicate mesoporous nanoparticles loaded with chlorhexidine for both anti-Enterococcus faecalis and mineralization properties | |
| NO20080202L (no) | Nanopartikulaere clopidogrel og aspirin kombinasjonsformuleringer | |
| CL2017002549A1 (es) | Uso de una composición de bismuto-tiol (bt), que sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana. | |
| Roberts et al. | An in vitro study of alginate oligomer therapies on oral biofilms | |
| EP2373791A4 (en) | COMPOSITIONS AND METHOD FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS AND THE EXTINGUISHING OR BZW. DECIMATION OF STAPHYLOCOCCUS AUREUS ON SURFACES | |
| JP2015502179A5 (https=) | ||
| JP2013150875A5 (https=) | ||
| AR090569A1 (es) | Agregados de nanoparticulas que contienen osteopontina y particulas que contienen calcio y/o estroncio | |
| NO20073559L (no) | Nanopartiklulaere tacrolimus-formuleringer | |
| RU2017104218A (ru) | Система для введения композиции для ухода за полостью рта | |
| EA201070036A1 (ru) | Наноразмерные молочно-кислые бактерии | |
| EA200870531A1 (ru) | Покрытие для фильтра для улавливания частиц | |
| WO2009117410A8 (en) | Formation of nanostructured particles of poorly water soluble drugs and recovery by mechanical techniques | |
| MX2011007196A (es) | Composiciones de enjuague bucal que incluyen silice o materiales de silicato quimicamente modificados para su distribucion sostenida en las superficies dentales. | |
| Welch et al. | Investigation of the antibacterial effect of mesoporous magnesium carbonate | |
| JP2008520567A5 (https=) | ||
| CN106719817B (zh) | 氧化钇-三氧化二铁复合纳米抑菌材料 | |
| Fattah et al. | Antimicrobial and antibiofilm activity of biosynthesized silver nanoparticles against beta-lactamase-resistant Enterococcus faecalis | |
| NO20080403L (no) | Nanopartikulaere megestrolformuleringer | |
| WO2015024021A3 (en) | Antibacterial compounds | |
| Fang et al. | Antibacterial carbon dots integrating multiple mechanisms for selective Gram-positive bacteria elimination and infected wound healing acceleration | |
| Herrera-Cantú et al. | Quantic analysis of the adherence of a gram-negative bacteria in a HEPA filter | |
| Javedani Bafekr et al. | In vitro antibacterial activity of ceftazidime, unlike ciprofloxacin, improves in the presence of ZnO nanofluids under acidic conditions |